[EN] EP4 RECEPTOR AGONIST, COMPOSITIONS AND METHODS THEREOF<br/>[FR] AGONISTE DU RECEPTEUR EP4, COMPOSITIONS ET METHODES ASSOCIEES EP4 RECEPTOR AGONIST, COMPOSITIONS AND METHODS THEREOF
申请人:MERCK FROSST CANADA LTD
公开号:WO2005116010A1
公开(公告)日:2005-12-08
This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors, their use or a formulation thereof in the treatment of glaucoma and other conditions, which are related to elevated intraocular pressure in the eye of a patient. This invention further relates to the use of the compounds of this invention for mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts.
这项发明涉及前列腺素E2受体EP4亚型的有效选择性激动剂,其在治疗青光眼和其他与患者眼内高眼压相关的疾病中的使用或配方。此发明还涉及利用本发明化合物介导成骨细胞和破骨细胞的骨塑造和重塑过程。